Megakaryocytopoiesis: Growth factors, cell cycle and gene expression

Anticancer Research

Volumn 18, Issue 3 B, 1998, Pages 1871-1882

  Baatout, Sarah ^a  

^a BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

Author keywords

Cell cycle; Gene expression; Growth factor; Megakaryocyte regulation; Polyploidization

Indexed keywords

CYTOKINE; GROWTH FACTOR;

CELL CYCLE; CELL INTERACTION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; THROMBOCYTOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0031948061     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. Aglietta M, Monzeglio C, Sanavio F, Apra F, Morelli S, Stacchini A, Piacibello W, Bussolino F, Bagnara G, Zauli G, Stern AC, Gavosto F: In vivo effect of human granulocyte-macrophage colony-stimulating factor on megakaryocytopoiesis. Blood 77: 1191-1194, 1991.
2. Alavi JB, Hansell J: Labelled cells in the investigation of hematologic disorders. Semin Nucl Med 14: 208-215, 1984.
3. Andrews RG, Knitter GH, Bartelmez SH, Langley KE, Farrar F, Hendren RW, Appelbaum FR, Bernstein ID, Zsebo KM: Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 78: 1975-1980, 1991.
4. Andrews RG, Bensinger WI, Knitter GH, Bartelmez SH, Longin K, Bernstein ID, Appelbaum FR, Zsebo KM: The ligand for c-kit stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80: 2715-2720, 1992.
5. Avraham H, Vannier E, Cowley S, Jiang SX, Chi S, Dinarello CA, Zsebo KM, Groopman JE: Effects on stem cell factor, c-kit ligand on human megakaryocytic cells. Blood 79: 365-372, 1992.
6. Baatout S: Interleukin-6 and megakaryocytopoiesis: an update. Ann Hematol 73: 157-162, 1996.
7. Baatout S: Thrombopoietin. A review. Haemostasis 27: 1-8, 1997.
8. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu C-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 77: 1117-1123, 1994.
9. Benjamin WR, Tare NS, Hayes TJ, Becker JM, Anderson TD: Regulation of hemopoiésis in myelosuppressed mice by human recombinant IL-1 alpha. J Immunol 142: 792-799, 1989.
10. Berridge MV, Fraser JK, Carter JM, Lin FK: Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood 72: 970-977, 1988.
11. Bikalfi A, Han ZC, Furhmann G: Interactions of fibroblast growth factors with murine megakaryocytopoiesis and megakaryocytic cell lines. Blood 80: 1905-1913, 1992.
12. Breton-Gorius J, Favier R, Guichard J, Cherif D, Berger R, Debili N, Vainchenker W, Douay L: A new congenital dysmegakaryo-cytopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet α-granules and chromosome 11 deletion at 11q23. Blood 85: 1805-1813, 1994.
13. Briddell RA, Bruno E, Cooper RJ, Brandt JE, Hoffman R: Effect of c-kit ligand on in vitro human megakaryocytopopiesis. Blood 78: 2854-2859, 1991.
14. Brodsky WY, Uryvaeva IV: Cell polyploidy: its relation to tissue growth and function. Int Rev Cytol 50: 275-282, 1977.
15. Bruno E, Briddell RA, Cooper RJ, Hoffman R: Effect of recombinant interleukin-11 on human megakaryocyte progenitor cells. Exp Hematol 19: 378-385, 1991.
16. Bruno E, Briddell RA, Cooper RJ, Brandt JE, Hoffman R: Recombinant GM-CSF/IL3 fusion protein. Its effects on in vitro human megakaryocytopoiesis. Exp Hematol 20: 494-500, 1992.
17. Burstein SA, Mei RL, Henthorn J, Henthorn J, Friese P, Turner K: Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol 153: 305-311, 1992.
18. Carlo Stella C, Cazzola M, Ganser A, Bergamaschi G, Pedrazzoli P, Hoelzer D, Ascari E: Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-MK, BFU-E and CFU-GM). Blood 72: 1293-1299, 1988.
19. Carlo Stella C, Cazzola M, Bergamaschi G, Bemasconi P, Deza L, Invernizi R, Pedrazzoli P: Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia 3: 363-366, 1989.
20. Carrington PA, Hill RJ, Levin J, Verotta D: Effects of interleukin 3 and interleukin 6 on platelet recovery in mice treated with 5-fluorouracil. Exp Hematol 20: 462-469, 1992.
21. Chang CL, Long MW: Inactivation of CDC2 kinase during endomitotic DNA synthesis in human erytholeukemia (HEL) cells. Exp Hematol 20: 446-452, 1993.
22. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Blume KG: Granulocyte Colony-Stimulating Factor 'Mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81: 2031-2035, 1993.
23. Collins C, Livingston RB, Ellis G, Caron D: Effect of PIXY321 on hematologic recovery after high-dose cyclophosphamide (CTX), etoposide (VP-16) and cisplatin (CDDP) (CEP) in women with breast cancer (abst.) Blood 82 (suppl 1): 366a, 1993.
24. Cox LH, Downs T, Dagg K, Henthom J, Burstein SA: Interleukin-6 mRNA and protein increase in vivo following induction of acute thrombocytopenia in mice. Blood 77: 286-293, 1991.
25. Datta NS, Williams JL, Long MW: The role of cyclin D3- and cyclin E-cell division kinase complexes in megakaryocyte endomitosis. Blood 82: 209a, 1993.
26. Debili N, Wendung F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchencker W: The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 85: 391-401, 1995.
27. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-mpl ligand. Nature 369: 533-537, 1994.
28. Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo PH, Mignotte V: Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 11: 4678-4683, 1996.
29. D'Hondt V, Weynants P, Humblet Y, Guillaume T, Canon J-L, Beauduin M, Duprez P, Longueville J, Mull R, Chatelain C, Symann M: Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: A placebo-controlled randomized phase Ib study. J Clin Oncol 11: 2063-2071, 1993.
30. D'Hondt V, Humblet Y, Guillaume T, Baatout S, Chatelain C, Berliere M, Longueville J, Feyens AM, De Greve J, Van Oosterom A, Von Graffenried B, Donnez J, Symann M: Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: A multicentric placebo-controlled, randomized phase Ib study. Blood 85: 2347-2353, 1995.
31. Eaton DL, de Sauvage FJ: Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 25: 1-10, 1997.
32. Ebbe S, Stohlman F Jr: Stimulation of thrombocytopoiesis in irradiated mice. Blood 35: 783-792, 1970.
33. Ebbe S, Phalen E: Does autoregulation of megakaryocytopoiesis occur? Blood Cells 5: 123-138, 1979.
34. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end stage renal disease with recombinant human erythropoietin. N Engl J Med 136: 73-85, 1987.
35. Fraser JK, Lin FK, Berridge MV: Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL. Exp Hematol 16: 836-842, 1988.
36. Fraser JK, Tan AS, Lin F-K, Berridge MV: Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. Exp Hematol 17: 10-16, 1989.
37. Gallicchio VS: Accelerated recovery of hematopoiesis following sublethal whole body irradiation with recombinant murine interleukin-1 (IL-1). J Leuk Biol 43: 211-215, 1988.
38. Ganser A, Carlo Stella C, Greher J, Volkers B, Hoelzer D: Effect of recombinant interferons alpha and gamma on human bone marrow derived megakaryocyte progenitor cells. Blood 70: 1173-1178, 1987.
39. Gastl G. Plante M, Finstad CL: High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 83: 433-441, 1993.
40. Gewirtz AM, Bruno E, Elwell J, Huffman R: In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man. Blood 61: 384-388, 1983.
41. Gewirtz AM: Megakaryocytopoiesis: The state of the art. Thromb Haemost 74: 2Q4-209, 1995.
42. Glaspy JA, Golde DW: Granulocyte colony-stimulating factor (G-CSF): Preclinical and clinical studies. Semin Oncol 19: 386-394, 1992.
43. Grafi G, Larkins BA: Endoreduplication in maize endosperm: involvement of M phase-promoting factor inhibition and induction of S phase-related kinase. Science 269: 1262-1271, 1995.
44. Grigg A, Begley CG, Juttner CA, Szer J, Bik To L, Maher D, McGrath KM, Morstyn G, Fox RM, Sheridan WP: Effect of peripheral blood progenitor cells mobilised by filgramstim (G-CSF) on platelet recovery after high-dose chemotherapy. Bone Marrow Transplant 11(suppl 2): 23-29, 1993.
45. Gu XF, Allain A, Li L, Cramer EM, Tenza D, Caen JP, Han ZC: Expression of cyclin B in megakaryocytes and cells of other hematopoietic lines. C R Acad Sci III 316(12): 1438-1445, 1993.
46. Guy CT, Zhu W, Kaufman S, Robinson MO: E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol 16: 685-693, 1996.
47. Han ZC, Briere J, Abgrall JF et al: Spontaneous formation of megakaryocyte progenitors (CFU-MK) in primary thrombocythaemia. Acta Haematol 78: 51-53, 1987.
48. Han ZC, Bellucci S, Caen JP: Megakaryocytopoiesis: characterization and regulation in normal and pathological states. Int J Hematol 54: 3-14, 1991.
49. Han ZC, Lebeurier I, Caen JP: Negative regulation of megakaryocytopoiesis. In: Negative regulation of haematopoiesis. London/ Paris: John Libbey Eurotext, 1993.
50. Harker LA: Kinetics of thrombopoiesis. J Clin Invest 47: 458-475, 1968.
51. Harker LA, Finch CA: Thrombokinetics in man. J Clin Invest 48: 963-975, 1969.
52. Hatake K, Izumi T, Imagawa S, Ohta M, Miura Y: Macrophage colony-stimulating factor and platelet recovery after chemotherapy. Lancet 341: 963-975, 1993.
53. 111Indium-labelled human platelets. Br J Haematol 44: 269-275, 1980.
54. Hill RJ, Warren MK, Levin J: Stimulation of thrombopoiesis in mice by human recombinant interleukin-6. J Clin Invest 85: 1242-1247, 1990.
55. Hill RJ, Warren MK, Stenberg P, Levin J, Corash L, Drummond R, Baker G, Levin F, Mok Y: Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6. Blood 77: 42-48, 1991.
56. Hill RJ, Warren MK, Levin J, Gauldie J: Evidence that interleukin-6 does not play a role in the stimulation of platelet production after induction of acute thrombocytopenia. Blood 80: 346-351, 1992.
57. Hino M, Tojo A, Miyazono K, Urabe A, Takaku F: Effects of beta transforming growth factors on hematopoietic progenitor cells. Br J Haematol 70: 143-147, 1988.
58. Hoffman R: Interleukin-3: A potentially useful agent for treating chemotherapy- related thrombocytopenia. J Clin Oncol 11: 2057-2060, 1993.
59. Hunt P, Hokom MM, Wiemarm B, Leven RM, Arakawa T: Megakaryocyte proplatelet-like process formation in vitro is inhibited by serum prothrombin, a process which is blocked by matrix-bound glycosaminoglycans. Exp Hematol 21: 372-376, 1993.
60. Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, Okumura N, Nakahata T: Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood 78: 1969-1974, 1991.
61. Ishibashi T, Burstein SA: Interleukin 3 promotes the differentiation of isolated single megakaryocytes. Blood 67: 1512-1514, 1986.
62. Ishibashi T, Koziol JA, Burstein SA: Human recombinant erythropoietin promotes differentiation of murine megakaryocytes in vitro. J Clin Invest 79: 286-289, 1987.
63. Ishibashi T, Kimura H, Shikama Y et al: Inteleukin-6 is a potent thrombopoietic factor in vitro in mice. Blood 74: 1241-1248, 1989.
64. Japa J. A study of the morphology and development of the megakaryocytes. Br J Exp Pathol 24: 73-79, 1943.
65. Kamesaki H, Michaud G, Irving S, Suwabe N, Kamesaki S, Okuma M, Cossman J: TPA-induced arrest of erythroid differentiation is coupled with downregulation of GATA-I and upregulation of GATA-2 in an erythroid cell line SAM-1. Blood 87: 999-1005, 1996.
66. Kaushansky K, O'Hara PJ, Berkner K, Segal GM, Hagen HS, Adamson JW: Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci (USA) 83: 3101-3105, 1986.
67. Kaushansky K, Lok S, Holly R, Broudy V, Lin N, Bailey MC, Forstrom JW, Buddle MM, Dort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC: Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 369: 568-572, 1994.
68. Kikuchi J, Furukawa Y, Iwase S, Terui Y, Nakamura M, Kitagawa S, Kitagawa M, Komatsu N, Miura Y: Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation: involvement of cyclin-dependent kinase inhibitor p21 in polyploidization. Blood 89: 11-20, 1997.
69. Kimura H, Ohkoshi T, Matsuda S, Uchida T, Kariyone S: Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes. Acta Haematol 79: 1-6, 1988.
70. Kimura H, Ishibashi T, Uchida T, Maruyama Y, Friese P, Burstein SA: Interleukin 6 is a differentiation factor for human megakaryocytes in vitro. Eur Immunol 20: 1927-1931, 1990.
71. Kishimoto T: The biology of interleukin-6. Blood 74: 1-10, 1989.
72. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science, 258: 593-595, 1992.
73. Kiss C, Surrey S, Shreiber AD, Schwartz E, McKenzie SE: Human c-kit ligand (stem cell factor) induces platelet Fc receptor expression in megakaryoblastic cells. Exp Hematol 24: 1232-1237, 1996.
74. Kiss C, Cesano A, Zsebo KM, Clark SC, Santoli D: Human stem cell factor (c-kit ligand) induces an autocrine loop of growth in a GM-CSF-dependent megakaryocytic cell line. Leukemia 7: 235-243, 1993.
75. Komatsu N, Kirito K, Furukawa Y, Kikuchi J, Suwabe N, Yamamoto M, Miura Y: Cell-cycle-dependent regulation of erythropoietin receptor gene. Blood 89: 1182-1191, 1997.
76. Kuter DJ, Gminski DM, Rosenberg RD: Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood 79: 619-626, 1992.
77. Lehner CF, O'Farrell PH: The roles of Drosophila cyclin A and cyclin B in mitotic control. Cell 61: 535, 1990.
78. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH: GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol 13(1): 668-76, 1993.
79. Lengfelder E, Griesshammer M, Hehlmann R: Interferon-alpha in the treatment of essential thrombocythemia. Leuk Lymphoma 22: 135-142, 1996.
80. Leonard JP, Neben TY, Kozitza MK, Quinto CM, Goldman SJ: Constant subcutaneous infusion of rhIL-11 in mice: Efficient delivery enhances biological activity. Exp Hematol 24: 270-276, 1996.
81. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, I'runkard D, Ching AFT, Mathewes SL, Bailey MC, Forstom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369: 565-569, 1994.
82. Ludwig H, Linkesch W, Gisslinger H, Fritz E, Sinzinger H, Radaszkiewicz T, Chott A, Flener R, Miksche M: Interferon-alpha corrects thrombocytosis in patients with myeloproliferative disorders. Cancer Immunol Immunother 25: 266-273, 1987.
83. Mazur EM, Richtsmeier WJ, South K: Alpha-interferon: differential suppression of hematopoiesis in normal human long-term marrow cultures treated with recombinant human macrophage colony-stimulating factor. J Interferon Res 6: 199-206, 1986.
84. Mazur EM, Cohen JI, Wong GG, Clark SC: Modest stimulatory effect of recombinant human GM-CSF on colony growth from peripheral bone human megakaryocyte progenitor cells. Exp Hematol 15: 1128-1133, 1987.
85. McDonald TP, Cottrell M, Clift R: Regulation of megakaryocytopoiesis by acetylcholinesterase. Exp Hematol 13: 437a, 1985.
86. Mc Donald TP, Cottrell MB, Clift RE, Cullen WC, Lin FK: High doses of recombinant erythropoietin stimulate platetet production in mice. Exp Hematol 15: 719-721, 1987.
87. Metcalf D, Hilton D, Nicola NA: Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro. Blood 77: 2150-2156, 1991.
88. Methia N, Louache F, Vainchenker W, Wendling F: Oligodeoxynucleotides antisense to the proto-oncogene, a member of the hematopoietic cytokine receptor family: Molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 8: 2607-2611, 1993.
89. Mouthon MA, Bernard O, Mitjavila MT, Romeo PH, Vainchenker W, Mathieu-Mahul D: Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81: 647-655, 1993.
90. Nagata Y, Muro Y, Todokoro K: Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol 139: 449-456, 1997.
91. Navarro S, Dehili N, Le Coucdic JP, Klein B, Breton-Gorius J, Doly J, Vainchenker W: Interleukin-6 and its receptor are expressed by human megakaryocytes in vitro effects on proliferation and endoreplication. Blood 77: 461-471, 1991.
92. Odell TT, Jackson CW Jr, Reiter RS: Generation cycle of rat megakaryocytes. Exp Cell Res 53: 321-332, 1968.
93. Odell TT, Murphy JR, Jackson CW: Stimulation of megakaryocytopoiesis by acute thrombocytopenia in rats. Blood 48: 765-778, 1976.
94. Paulus JM, Maigne J, Keyhani E: Mouse megakaryocytes secrete acetylcholinesterase. Blood 58: 1100-1106, 1981.
95. Penington DG, Olsen TE: Megakaryocytes in states of altered platelet production: cell numbers, size and DNA content. Br J Haematol 18: 447-458, 1970.
96. Peschel C, Paul WE, O'Hara J, Green I: Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. Blood 70: 254-263, 1987.
97. Pevny L, Simon MC, Robertson E, Klein WH, Tsai F, D'Agati V, Orkin SH, Costantini F: Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349: 257-264, 1991.
98. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rondan G, Constantini F: Interleukin-6-deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13: 1189-1196, 1994.
99. Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD: Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol 11(12): 6116-27, 1991.
100. Robinson MO, Zhou W, Hokum M, Danilenko DM, Hsu RY, Atherton RE, Xu W, Mu S, Saris C, et al: The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice. PNAS USA 91: 12798-12810, 1994.
101. Sasaki H, Matsuda M, Lu Y, Ikuta K, Matsuyama S, Hirabayashi Y, Mitsui H, Matsumura T, Muramatsu M, Tsukada T, Aizawa S, rnoue T: A fraction unresponsive to growth inhibition by TGF-beta among the high proliferative potential progenitor cells in bone marrow of p53-deficient mice. Leukemia 11: 239-244, 1997.
102. Schafer AI: Bleeding and thrombosis in the myeloproliferative disorders. Blood 64: 1-11, 1984.
103. Shikama Y, Ishibashi T, Kimura H, Kawaguchi M, Uchida T, Maruyama Y: Transient effect of erythropoietin on thrombocytopoiesis in vivo in mice. Exp Hematol 20: 216-221, 1992.
104. Shivdasani R, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Sarris JM, Orkin SH: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MDGF in megakaryocyte development. Cell 81: 695-704, 1995.
105. Shivdasani R, Fujiwara Y, McDevitt MA, Orkin SH: A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16: 3965-3971, 1997.
106. Shivdasani RA, Fielder P, Keller GA, Orkin SH, de Sauvage FJ: Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice. Blood 90: 1821-1828, 1997.
107. Simon MC, Pevny L, Wiles MV, Keller G, Costantini F, Orkin SH: Rescue of erythroid development in gene targeted GATA-1-mouse embryonic stem cells. Nature Genet 1: 92-95, 1992.
108. Smith JW, Longo DL, Alvord WG, Janik JE, Sharfman WH, Gause BL, Curti BD, Creekmore SP, Holmlund JT, Fenton RG et al: The effects of treatment with interleukin-la on platelet recovery after high-dose carboplatin. N Engl J Med 328: 756-761, 1993.
109. Suzuki A, Takahashi T, Nakamura K: Thrombocytosis in patients with tumors producing colony stimulating factor. Blood 81: 2052-2059, 1992.
110. Tepler I, Elias L, Smith II J, Hussein M, Rosen G, Chang AYC, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA: A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87: 3607-3614, 1996.
111. Thiele J, Jensen B, Orth KH, Moedder B, Fischer R: Ultrastructure of megakaryocytes in the human bone marrow of patients with primary (essential)- thrombocythemia. J Submicro Cytol S Pathol 20: 671-681, 1988.
112. Tomer A, Harker LA, Burstein SA: Flow cytometric analysis of normal human megakaryocytes. Blood 71: 1244-1252, 1988.
113. Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M, Orkin SH: FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90: 109-114, 1997.
114. Tsuji-Takayama K, Tahata H, Harashima A, Nishida Y, Izumi N, Fukuda S, Ohta T, Kurimoto M: Interferon-gamma enhances megakaryocyte colony-stimulating activity in murine bone marrow cells. J Interferon Cytokine Res 16: 701-708, 1996.
115. Tsukada J, Misago M, Kikuchi M, Sato T, Ogawa R, Ota T, Oda S, Morimoto I, Chiba S, Eto S: Interaction between recombinant human erythropoietin and serum factor(s) on murine megakaryocyte colony formation. Blood 80: 37-46, 1992.
116. Usui T, Yoshida M, Abe K, Osada H, Isono K, Beppu T: Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J Cell Biol 115: 1275-1284, 1991.
117. Wang Z, Zhang Y, Kamen D, Lees E, Ravid K: Cyclin D3 is essential for megakaryocytopoiesis. Blood 1995. 86: 3783-3788, 1995.
118. Weiss MJ, Keller G, Orkin SH: Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Devel 8: 1194-1191, 1994.
119. Weiss MJ, Orkin SH: GATA transcription factors : key regulators of hematopoiesis. Exp Hematol 23: 99-107, 1995.
120. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: c-mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369: 571-578, 1994.
121. Wilhide CC, Van Dang C, Dispersio J, Kenedy AA, Bray PF: Overexpression of cyclin D1 in the DAMI megakaryocytic cell line causes growth arrest. Blood 86: 294-304, 1995.
122. Winerls CG, Pippard MJ, Dowrling MR, Olwer DO, Reid C, Cotes PM: Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic haemodialysis. Lancet 2: 1175-1183, 1986.
123. Wright JH: The histogenesis of the blood platelets. J Morphol 1910. 21: 263-275, 1910.
124. Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Takatsuki K: Effect of recombinant human interleukin-11 on rat megakaryocytopoiesis and thrombopoiesis in vivo: comparative study with interleukin-6. Br J Haematol 84: 16-23, 1993.
125. Zauli G, Visani G, Catani L: Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor B1, produced in normal amount, in patients with essential thrombocythemia. Br J Haematol 83: 14-20, 1993.
126. Zhang Y, Wang Z, Ravid K: The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem 271: 4266-4274, 1996.
127. Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, Malloy B, Hass P, Eaton D, Matthews W: In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84: 4045-4056, 1994.